Ojas, Baby Girl .
HRN: 24-76-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/26/2024
04/02/2024
IV
45mg
Q24
PSNB
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes